DE69717664D1 - Protein e25a, methoden zu dessen herstellung und anwendung - Google Patents
Protein e25a, methoden zu dessen herstellung und anwendungInfo
- Publication number
- DE69717664D1 DE69717664D1 DE69717664T DE69717664T DE69717664D1 DE 69717664 D1 DE69717664 D1 DE 69717664D1 DE 69717664 T DE69717664 T DE 69717664T DE 69717664 T DE69717664 T DE 69717664T DE 69717664 D1 DE69717664 D1 DE 69717664D1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- cancer
- nucleic acid
- refractory prostate
- hormone refractory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101001050472 Homo sapiens Integral membrane protein 2A Proteins 0.000 title 1
- 102100023351 Integral membrane protein 2A Human genes 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 206010062904 Hormone-refractory prostate cancer Diseases 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000002853 nucleic acid probe Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2556996P | 1996-09-06 | 1996-09-06 | |
| PCT/US1997/015606 WO1998010069A2 (en) | 1996-09-06 | 1997-09-05 | E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69717664D1 true DE69717664D1 (de) | 2003-01-16 |
Family
ID=21826823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69717664T Expired - Lifetime DE69717664D1 (de) | 1996-09-06 | 1997-09-05 | Protein e25a, methoden zu dessen herstellung und anwendung |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6093800A (de) |
| EP (1) | EP0942972B1 (de) |
| AT (1) | ATE229073T1 (de) |
| AU (1) | AU4181897A (de) |
| CA (1) | CA2265889A1 (de) |
| DE (1) | DE69717664D1 (de) |
| WO (1) | WO1998010069A2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2360347C (en) * | 1998-12-31 | 2013-05-07 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
| JP2003523721A (ja) * | 1998-12-31 | 2003-08-12 | カイロン コーポレイション | 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用 |
| ES2299276T3 (es) | 1998-12-31 | 2008-05-16 | Novartis Vaccines And Diagnostics, Inc. | Polipeptidos env del vih modificados. |
| US7935805B1 (en) * | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| JP3964678B2 (ja) | 1999-10-28 | 2007-08-22 | アジェンシス，インコーポレイテッド | ３６ｐ６ｄ５：分泌腫瘍抗原 |
| AU2002227077A1 (en) * | 2000-12-01 | 2002-06-11 | Duke University | Zinc alpha-2-glycoprotein as indicator of cancer |
| AU2002245108A1 (en) * | 2000-12-15 | 2002-07-30 | Origene Technologies, Inc. | Angiogenesis gene and modulators |
| WO2002083919A2 (en) * | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| US7211659B2 (en) | 2001-07-05 | 2007-05-01 | Chiron Corporation | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| EP2280074A3 (de) * | 2001-07-05 | 2011-06-22 | Novartis Vaccines and Diagnostics, Inc. | Antigene typ-b- und/oder typ-c-hiv-polypeptide codierende polynukleotide, polypeptide und deren verwendungen |
| US20030170614A1 (en) * | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| EP1427806A4 (de) * | 2001-08-31 | 2006-04-26 | Chiron Corp | Antigene hiv-typ-b-polypeptide codierende polynukleotide, polypeptide und verwendungen davon |
| US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| WO2004020999A1 (en) * | 2002-08-30 | 2004-03-11 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
| TR201807756T4 (tr) | 2006-09-26 | 2018-06-21 | Infectious Disease Res Inst | Sentetik adjuvan içeren aşı bileşimi. |
| US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| WO2008137500A2 (en) * | 2007-05-01 | 2008-11-13 | The Brigham And Women's Hospital | Immunosuppression with antibody against itm2a |
| EP2437753B1 (de) | 2009-06-05 | 2016-08-31 | Infectious Disease Research Institute | Synthetische glucopyranosyl-lipid-adjuvanzien und impfstoffzusammensetzungen die diese enthalten |
| AU2012243039B2 (en) | 2011-04-08 | 2017-07-13 | Immune Design Corp. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
| CN104363892A (zh) | 2012-02-07 | 2015-02-18 | 传染性疾病研究院 | 包含tlr4激动剂的改进佐剂制剂及其使用方法 |
| RS57420B1 (sr) | 2012-05-16 | 2018-09-28 | Immune Design Corp | Vakcine za hsv-2 |
| CA2909221A1 (en) | 2013-04-18 | 2014-10-23 | Immune Design Corp. | Gla monotherapy for use in cancer treatment |
| US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
| US11801223B2 (en) | 2013-12-31 | 2023-10-31 | Access To Advanced Health Institute | Single vial vaccine formulations |
| BR112018074352B1 (pt) | 2016-06-01 | 2021-11-30 | Infectious Disease Research Institute | Partículas de nanoalume contendo um agente de dimensionamento |
| CN111315406A (zh) | 2017-09-08 | 2020-06-19 | 传染病研究所 | 包括皂苷的脂质体调配物及其使用方法 |
| CN114340665A (zh) | 2019-05-25 | 2022-04-12 | 传染病研究所 | 用于对佐剂疫苗乳剂进行喷雾干燥的组合物和方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE342356T1 (de) * | 1992-11-05 | 2006-11-15 | Sloan Kettering Inst Cancer | Prostata-spezifisches membranantigen |
-
1997
- 1997-09-05 EP EP97939804A patent/EP0942972B1/de not_active Expired - Lifetime
- 1997-09-05 WO PCT/US1997/015606 patent/WO1998010069A2/en active IP Right Grant
- 1997-09-05 DE DE69717664T patent/DE69717664D1/de not_active Expired - Lifetime
- 1997-09-05 AT AT97939804T patent/ATE229073T1/de not_active IP Right Cessation
- 1997-09-05 US US08/924,570 patent/US6093800A/en not_active Expired - Fee Related
- 1997-09-05 CA CA002265889A patent/CA2265889A1/en not_active Abandoned
- 1997-09-05 AU AU41818/97A patent/AU4181897A/en not_active Abandoned
-
1999
- 1999-11-29 US US09/451,214 patent/US7030232B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0942972A2 (de) | 1999-09-22 |
| WO1998010069A3 (en) | 1998-05-07 |
| CA2265889A1 (en) | 1998-03-12 |
| ATE229073T1 (de) | 2002-12-15 |
| WO1998010069A2 (en) | 1998-03-12 |
| US6093800A (en) | 2000-07-25 |
| EP0942972B1 (de) | 2002-12-04 |
| US7030232B1 (en) | 2006-04-18 |
| AU4181897A (en) | 1998-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69717664D1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
| DE60126592D1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
| HUP0102992A2 (hu) | Szcintigráfiai célokat szolgáló specifikus kötőmolekulák, a molekulákat tartalmazó konjugátumok és az angiogenezis kezelésére szolgáló terápiás eljárások | |
| ATE345399T1 (de) | Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten | |
| DE60134178D1 (de) | Trp8 krebsmarker | |
| BR9917218A (pt) | Anticorpos monoclonais, antìgenos, e diagnósticoe terapia de doenças malignas | |
| CY1105212T1 (el) | Αντισωματα αντι-april και κυτταρα υβριδωματος | |
| WO2004092338A3 (en) | Compositions, splice variants and methods relating to cancer specific genes and proteins | |
| MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
| DE69837529D1 (de) | Proteinmarker für lungenkrebs und deren verwendung | |
| DE69231245D1 (de) | Veraendertes gen bei menschlichem colorektalem-krebs | |
| TR200103560T2 (tr) | Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı | |
| AR026946A1 (es) | Osteoprotegerina/receptores de factores de necrosis de tumores | |
| EP2263679A3 (de) | Auf Proteine in Verbindung mit Krebs zielende RNAi-Sonde | |
| DE60032784D1 (de) | Markerproteine für prostatakrebs | |
| EP1377596A4 (de) | Ttk in der diagnose und als therapeutisches target bei krebs | |
| WO2003105773A3 (en) | MUTATIONS OF PDGFRA ACTIVATED AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS | |
| WO2002040672A3 (en) | Compositions and methods relating to breast specific genes and proteins | |
| DE60044350D1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs | |
| WO2002064741A3 (en) | Compositions and methods relating to breast specific genes and proteins | |
| AP2000001917A0 (en) | Gene encoding labyrinthin, a marker for cancer. | |
| DE60014064D1 (de) | Einetenascin-c isoform als marker für neoplasmen | |
| ATE366936T1 (de) | Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose | |
| WO2002040673A3 (en) | Compositions and methods relating to lung specific genes and proteins | |
| DE69636041D1 (de) | Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |